Ex vivo effect of vascular wall stromal cells secretome on enteric ganglia

BACKGROUND: Mesenchymal stromal cell (MSC)-based therapy is currently under study to treat inflammatory bowel diseases. MSC bioactive products could represent a valid alternative to overcome issues associated with systemic whole-cell therapies. However, MSC anti-inflammatory mechanisms differ betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Dothel, Giovanni, Bernardini, Chiara, Zannoni, Augusta, Spirito, Maria Rosaria, Salaroli, Roberta, Bacci, Maria Laura, Forni, Monica, Ponti, Fabrizio De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737320/
https://www.ncbi.nlm.nih.gov/pubmed/31543681
http://dx.doi.org/10.3748/wjg.v25.i33.4892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737320/
https://www.ncbi.nlm.nih.gov/pubmed/31543681
http://dx.doi.org/10.3748/wjg.v25.i33.4892

Ejemplares similares